Last updated 2026-09-06
- Went public on SIX Swiss Exchange (SHLTN), 2000
- Raised $29.5M Follow-on PO led by Existing shareholders, Sep 2025
- Raised $35M PIPE led by Valuebase, Dec 2020
Total raised
$124.7M
Last: Undisclosed Round 2025-12
Stage
Public
Founded
1987
Headcount
526
HQ
Tel Aviv-Yafo, Israel
Sector
Healthcare Technology
About
SHL Telemedicine develops and markets personal telemedicine systems and provides medical call center services, with a focus on cardiovascular and related diseases. The company offers solutions to end-users, healthcare professionals, health insurance companies, hospitals, and clinics. Their services and devices, such as the SmartHeart® portable 12-lead ECG, enable remote diagnosis and monitoring, aiming to reduce mortality, improve quality of life, and lower healthcare costs. SHL operates 24/7 telemedicine centers in Israel and Germany, with global services based on cloud technology.
Funding history · 6 rounds · $124.7M total
7 events/rounds · $124.7M Total Funding: $97.7M in Public Equity, $27.0M in Debt
Sep 2025
★ Existing shareholders
Feb 2023
Feb 2021
Dec 2020
Mar 2017
★ Israeli financial institution★ Certain Israeli financial institution★ Certain Israeli financial institutions
Mar 2000
Headcount over time
526 employees (2026-09) · 1 point
Offices
Tel Aviv-Yafo, Israel · HQ / main office
Show all offices (2 more)
- Hauppauge, United States
- Mnchen, Germany
Q&A
- When did SHL Telemedicine launch its SmartHeart® D2C Membership in the US?
- SHL Telemedicine officially launched its SmartHeart® D2C Membership in the US in May 2024, following a successful soft launch.
- What significant partnership did SHL Telemedicine announce in December 2024?
- In December 2024, SHL Telemedicine partnered with DocGo to revolutionize patient access to cardiovascular care and to put 12-lead devices in health care units.
- What were the key findings from the Imperial College London study on SHL Telemedicine’s SmartHeart®?
- An Imperial College London study, published in April 2024, showed groundbreaking final results for SHL Telemedicine’s SmartHeart® in post-ACS patient care. Further results from the TELE-ACS Clinical Trial were presented at ACC 24 in February 2024.
- What strategic move did SHL Telemedicine make in Israel in May 2024?
- In May 2024, SHL Telemedicine expanded its offering in Israel with the introduction of a groundbreaking at-home biomarker blood test.
- What was the outcome of SHL Telemedicine’s SmartHeart® Technology participation in the US Army Project Convergence – Capstone 4 Experiment?
- SHL Telemedicine’s SmartHeart® Technology triumphed in the US Army Project Convergence – Capstone 4 Experiment in April 2024.
- What was SHL Telemedicine's financial performance in the first half of 2025?
- In the first half of 2025, SHL Telemedicine reported a loss of US$0.27 per share, compared to a US$0.24 loss in the first half of 2024.
- What is the status of a possible investment in SHL Telemedicine's Israeli activity?
- In June 2024, SHL Telemedicine confirmed discussions regarding a possible investment in its Israeli activity.
- When did SHL Telemedicine commence trading on NASDAQ?
- SHL Telemedicine commenced trading on NASDAQ under the symbol "SHLT" in March 2023.
Team · 9
Dr. Itamar Offer
Chairman of the Board of Directors
David Arnon
CEO
Lior Haalman
CFO
Dr. Yishay Szekely
Medical Director SHL Telemedicine
Josef Woerner
Managing Director – SHL Telemedizin, Germany
Ido Nouberger
executives
Nir Rotenberg
executives
Amiri Shoham
executives
Orna Carni
executives
Sectors & technology
Primary sector
Healthcare Technology
Technologies
Target customers
Business model
Subscription-based servicesDevice sales
Tags
mobile-applicationsremote-monitoringhome-carechronic-diseasecardiologymonitoringtelemedicineheart-failurepulmonarydigital-healthcareecginsurance-companiesdiagnosticsdoctorssoftware-applicationshealthcare-providers
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)
External links
| Website | shl-telemedicine.com |
|---|---|
| linkedin.com/company/351032 | |
| facebook.com/shahal.co.il | |
| YouTube | youtube.com/channel/UCL9MgtVZKmmqbdST-AARJag |
Identifiers & details
| Legal name | SHL Telemedicine Ltd. |
|---|---|
| Founded | 1987 |
| Employees (exact) | 526 |
| Offices | Hauppauge; Mnchen |
| Market cap | $33.6M |
| Status reason | Public on SIX on Apr, 2000; Public on NASDAQ on Mar, 2023 |
Acquisitions & public offerings
| Type | Date | Exchange | Ticker | Amount |
|---|---|---|---|---|
| IPO | 2000 | SIX Swiss Exchange | SHLTN |
Radar intelligence
Patents
| EPO | 8 |
|---|
Web history (Wayback)
| Domain | shl-telemedicine.com |
|---|
Certificate / subdomain footprint
| Subdomains | 2 |
|---|
Israeli Companies Registrar (רשם החברות / ICA)
| Registrar # (ח.פ.) | 512527383 |
|---|---|
| Status | פעילה |
| Corp type | ישראלית חברה פרטית |
| Incorporated | 1997-09-02 |
| Purpose | לעסוק בסוגי עיסוק שפורטו בתקנון |
| Liability | לא מוגבלת |
| In violation (unfiled) | no |
| Last annual report | 2026 |
| Active charges / liens | 0 |
| Registry events | 5 — people (3), other (1), annual_report (1) |
| Registered address | אלון יגאל 90 תל אביב - יפו |
Recent registry events
| Date | Event |
|---|---|
| 2026-06-30 | עדכון דירקטורים-הסרת דירקטור |
| 2026-06-30 | עדכון דירקטורים-הוספת דירקטור |
| 2026-02-26 | עדכון כתובת ו/או מען דיגיטלי |
| 2026-02-25 | עדכון בעלי תפקידים |
| 2026-08-11 | דו~ח שנתי |